Author:
Finley Stacey D.,Popel Aleksander S.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Rennel ES, Harper SJ, Bates DO. Therapeutic potential of manipulating VEGF splice isoforms in oncology. Futur Oncol. 2009;5(5):703–12.
2. Bates DO, Cui T-G, Doughty JM, Winkler M, Sugiono M, Shields JD, et al. VEGF165b, and inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 2002;62:4123–31.
3. Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, et al. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci. 2008;121:3487–95.
4. Dokun AO, Annex BH. The VEGF165b "ICE-o-form" puts a chill on the VEGF story. Circul Res. 2011;109:246–7.
5. Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, et al. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circul Res. 2011;109:e14–26.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献